GENE ONLINE|News &
Opinion
Blog

Shionogi
Special Antibiotic Resistance
World Premiere of Documentary-style Film on the Battle Against Antibiotic Resistance
2023-09-06
Special Hong KongGlobal Events
2023 International Healthcare Week: Showcasing Emerging Competencies of Hong Kong’s Biomedical Industry
2023-06-05
Innovation hepatitis B
Shionogi, NEC Team Up on Hepatitis B Vaccine
2022-04-20
Innovation Drug Approval
Shionogi and Aichi Prefecture Extends Cooperation on Preventing Drug Abuse
2022-04-08
Asia-Pacific COVID-19
Shionogi and Ildong Team up to Co-Develop Oral COVID-19 Pill
2021-11-19
Asia-Pacific COVID-19
Daiichi Sankyo to Launch mRNA COVID-19 Vaccine in 2022, Shionogi Presents Clinical Results of COVID-19 Oral Drug
2021-10-22
Asia-Pacific COVID-19 Treatment
Shionogi’s COVID-19 Oral Drug and Nasal Vaccine Makes Headway in Trials
2021-09-29
COVID-19 Vaccine
Japan’s Shionogi to Provide 120 Million Doses of COVID-19 Vaccines Annually
2021-07-08
COVID-19 Anti-COVID Drug
Japan’s Shionogi Grants US Company the Rights to Develop a Repurposed Allergic Rhinitis Drug as a COVID-19 Cure
2021-01-29
Trials & Approvals Influenza
Xofluza Garners FDA Approval for Influenza Prevention Following Contact with Infected Patients
2020-11-26
Healthcare
Shionogi Accesses Ping An’s Database of 300 Million People in China to Design New Healthcare Services
2020-11-07
COVID-19
Weekly Cover：Updates on COVID-19 in Asia
2020-04-08
Trials & Approvals Alzheimer's Disease
Spotlight: Shionogi’s Big Bet on Tetra Therapeutics
2020-03-07
LATEST
Lotus Pharma Expands in Southeast Asia with Alpha Choay Acquisition from Sanofi
2024-09-06
Indian CDMO Stocks in the Spotlight: US House to Vote on BIOSECURE Act Next Week
2024-09-06
Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery
2024-09-06
Illumina Wins EU Court Battle, Dodges Fine, but Grail Deal Already Void
2024-09-05
Breaking New Ground for Clinical Trials with AI/ML Applications
2024-09-05
InMed Pharmaceuticals’ Positive Market Response to Cannabinoid Analog INM-901 for Alzheimer’s Treatment
2024-09-04
Alnylam Pharma Shares Dip Despite Positive Phase 3 HELIOS-B Heart Disease Results
2024-09-04
READ MORE
EVENT
2024-09-11
2024 Bio Asia Pacific
Bangkok, Thailand
2024-09-13
ESMO Congress 2024
Barcelona, Spain
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-10
BioJapan / Regenerative Medicine Japan / healthTECH JAPAN 2024
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top